Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 3
2009 1
2011 1
2013 1
2014 4
2015 6
2016 6
2017 4
2018 11
2019 11
2020 11
2021 9
2022 6
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for elisabetta setting
Search for Elisabetta Settin instead (1 results)
Microsatellite instability in Gastric Cancer: Between lights and shadows.
Puliga E, Corso S, Pietrantonio F, Giordano S. Puliga E, et al. Cancer Treat Rev. 2021 Apr;95:102175. doi: 10.1016/j.ctrv.2021.102175. Epub 2021 Mar 1. Cancer Treat Rev. 2021. PMID: 33721595 Free article. Review.
Conversely, conflicting outcomes have been reported in chemotherapy settings. Due to the clinical relevance of these observations, in this review we report and discuss the molecular, pathological, prognostic, and predictive features of MSI gastric tumors....
Conversely, conflicting outcomes have been reported in chemotherapy settings. Due to the clinical relevance of these observations, in …
Effectiveness of a multi-layer silicone-adhesive polyurethane foam dressing as prevention for sacral pressure ulcers in at-risk in-patients: Randomized controlled trial.
Forni C, Gazineo D, Allegrini E, Bolgeo T, Brugnolli A, Canzan F, Chiari P, Evangelista A, Grugnetti AM, Grugnetti G, Guberti M, Matarese M, Mezzalira E, Pierboni L, Prosperi L, Sofritti B, Tovazzi C, Vincenzi S, Zambiasi P, Zoffoli C, Ambrosi E; Multischiume Group. Forni C, et al. Int J Nurs Stud. 2022 Mar;127:104172. doi: 10.1016/j.ijnurstu.2022.104172. Epub 2022 Jan 8. Int J Nurs Stud. 2022. PMID: 35124474 Free article. Clinical Trial.
DESIGN: Open-label, parallel group, multi-center randomized controlled trial. PARTICIPANTS AND SETTING: 709 in-hospital patients at risk for pressure ulcers from 25 medical, surgical, and intensive care units of 12 Italian hospitals. ...
DESIGN: Open-label, parallel group, multi-center randomized controlled trial. PARTICIPANTS AND SETTING: 709 in-hospital patients at r …
Key Enabling Technologies for Point-of-Care Diagnostics.
Primiceri E, Chiriacò MS, Notarangelo FM, Crocamo A, Ardissino D, Cereda M, Bramanti AP, Bianchessi MA, Giannelli G, Maruccio G. Primiceri E, et al. Sensors (Basel). 2018 Oct 24;18(11):3607. doi: 10.3390/s18113607. Sensors (Basel). 2018. PMID: 30355989 Free PMC article. Review.
Moreover, they are becoming more and more integrated with everyday objects, such as smartphones, and their spread among unskilled common people, has the power to improve the quality of life, both in the developed world and in low-resource settings. The future success of th …
Moreover, they are becoming more and more integrated with everyday objects, such as smartphones, and their spread among unskilled common peo …
Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022.
Lampertico P, Degasperi E, Sandmann L, Wedemeyer H; Delta Cure 2022 Working Group. Lampertico P, et al. JHEP Rep. 2023 Jun 28;5(9):100818. doi: 10.1016/j.jhepr.2023.100818. eCollection 2023 Sep. JHEP Rep. 2023. PMID: 37593170 Free PMC article. Review.
The discovery of the entry inhibitor bulevirtide has represented a breakthrough in HDV treatment, by demonstrating high rates of viral suppression in phase II and III trials, results which have been confirmed in real-world settings and in patients with compensated advanced …
The discovery of the entry inhibitor bulevirtide has represented a breakthrough in HDV treatment, by demonstrating high rates of viral suppr …
Immunotherapy of brain metastases: breaking a "dogma".
Di Giacomo AM, Valente M, Cerase A, Lofiego MF, Piazzini F, Calabrò L, Gambale E, Covre A, Maio M. Di Giacomo AM, et al. J Exp Clin Cancer Res. 2019 Oct 17;38(1):419. doi: 10.1186/s13046-019-1426-2. J Exp Clin Cancer Res. 2019. PMID: 31623643 Free PMC article. Review.
Along this line, neuro-oncology undoubtedly represents an additional area of active investigation and of growing interest to support medical oncologists in the evaluation of clinical responses of brain metastases to ICI treatment, and in the management of neurologic immune-relate …
Along this line, neuro-oncology undoubtedly represents an additional area of active investigation and of growing interest to support medical …
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.
Vistisen D, Carstensen B, Elisabetta P, Lanzinger S, Tan EC, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Núñez J, Ha KH, Halvorsen S, Langslet G, Karasik A, Nyström T, Niskanen L, Guleria S, Klement R, Carrasco M, Foersch J, Shay C, Koeneman L, Hoti F, Farsani SF, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K; EMPRISE EU; East Asia Study Group. Vistisen D, et al. Cardiovasc Diabetol. 2023 Aug 31;22(1):233. doi: 10.1186/s12933-023-01963-9. Cardiovasc Diabetol. 2023. PMID: 37653496 Free PMC article.
This study compared risk of cardiovascular events in patients within routine care settings in Europe and Asia with type 2 diabetes (T2D) initiating empagliflozin compared to dipeptidyl peptidase-4 inhibitors (DPP-4i) stratified by pre-existing CVD and history of heart fail …
This study compared risk of cardiovascular events in patients within routine care settings in Europe and Asia with type 2 diabetes (T …
NanoString in the screening of genetic abnormalities associated with thyroid cancer.
Macerola E, Poma AM, Basolo F. Macerola E, et al. Semin Cancer Biol. 2022 Feb;79:132-140. doi: 10.1016/j.semcancer.2020.10.004. Epub 2020 Oct 19. Semin Cancer Biol. 2022. PMID: 33091600 Review.
In the setting of cancer pathology, molecular characterization of tumors providing diagnostic and predictive information is acquiring more and more relevance. ...
In the setting of cancer pathology, molecular characterization of tumors providing diagnostic and predictive information is acquiring …
Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer?
Fenocchio E, Filippi R, Lombardi P, Quarà V, Milanesio M, Aimar G, Leone F, Aglietta M. Fenocchio E, et al. Cancers (Basel). 2019 Oct 12;11(10):0. doi: 10.3390/cancers11101547. Cancers (Basel). 2019. PMID: 31614884 Free PMC article. Review.
A randomized trial exploring the role of chemoradiotherapy in this setting is now ongoing in the US (RTOG-0848). Overall, the management of localized pancreatic adenocarcinoma is evolving. ...
A randomized trial exploring the role of chemoradiotherapy in this setting is now ongoing in the US (RTOG-0848). Overall, the managem …
ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen.
Pepe G, Sfogliarini C, Rizzello L, Battaglia G, Pinna C, Rovati G, Ciana P, Brunialti E, Mornata F, Maggi A, Locati M, Vegeto E. Pepe G, et al. Biomed Pharmacother. 2021 Dec;144:112274. doi: 10.1016/j.biopha.2021.112274. Epub 2021 Oct 12. Biomed Pharmacother. 2021. PMID: 34653752 Free article.
We observed that 4HT and TAM induce estrogen antagonist effects when used at nanomolar concentrations, while pharmacological concentrations that are reached by TAM in clinical settings regulate the expression of VEGFalpha and other immune activation genes by ERalpha- and G …
We observed that 4HT and TAM induce estrogen antagonist effects when used at nanomolar concentrations, while pharmacological concentrations …
The Role of Photodynamic Therapy in the Treatment of Vulvar Intraepithelial Neoplasia.
Tosti G, Iacobone AD, Preti EP, Vaccari S, Barisani A, Pennacchioli E, Cantisani C. Tosti G, et al. Biomedicines. 2018 Feb 2;6(1):13. doi: 10.3390/biomedicines6010013. Biomedicines. 2018. PMID: 29393881 Free PMC article. Review.
CONCLUSIONS: the real benefit of photodynamic therapy in the setting of vulvar intraepithelial neoplasia lies in its ability to treat multi-focal disease with minimal tissue destruction, preservation of vulvar anatomy and excellent cosmetic outcomes. ...
CONCLUSIONS: the real benefit of photodynamic therapy in the setting of vulvar intraepithelial neoplasia lies in its ability to treat …
73 results